Drug    DrugBank | All Description Patterns💬 Info on mouse-over

No.	Drug (Description in trials)	DrugBank	KEGG DRUG	KEGG GENES	KEGG PATHWAY On map, Yellow: Drug target genes	Disease ID
1	Ly03003 ( rotigotine, extended-release microspheres)	Rotigotine	[1] D05768 💬	[1] DRD2 💬	[8] Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway	[1]  6  💬
2	Ly03003 (rotigotine extended release microspheres for intramuscular [im] injection)	Rotigotine	[1] D05768 💬	[1] DRD2 💬	[8] Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway	[1]  6  💬
3	Ly03003( the name of rotigotine)	Rotigotine	[1] D05768 💬	[1] DRD2 💬	[8] Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway	[1]  6  💬
4	Ly03003(rotigotine,extended-release microspheres)	Rotigotine	[1] D05768 💬	[1] DRD2 💬	[8] Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway	[1]  6  💬
5	Neupro	-	-	-	-	[1]  6  💬
6	Neupro (reference)	-	-	-	-	[1]  6  💬
7	Neupro 2 mg/24 h parche transdérmico	-	-	-	-	[1]  6  💬
8	Neupro 2 mg/24 h transdermal patch	-	-	-	-	[1]  6  💬
9	Neupro 2mg/24 h transdermal patch	-	-	-	-	[1]  6  💬
10	Neupro 2mg/24h transdermal patch	-	-	-	-	[1]  6  💬
11	Neupro 4 mg/24 h parche transdérmico	-	-	-	-	[1]  6  💬
12	Neupro 4 mg/24 h transdermal patch	-	-	-	-	[1]  6  💬
13	Neupro 4mg/24 h transdermal patch	-	-	-	-	[1]  6  💬
14	Neupro 4mg/24h transdermal patch	-	-	-	-	[1]  6  💬
15	Neupro 4mg/24hr transdermal patch	-	-	-	-	[1]  6  💬
16	Neupro 6 mg/24 h parche transdérmico	-	-	-	-	[1]  6  💬
17	Neupro 6 mg/24 h transdermal patch	-	-	-	-	[1]  6  💬
18	Neupro 6mg/24 h transdermal patch	-	-	-	-	[1]  6  💬
19	Neupro 6mg/24h transdermal patch	-	-	-	-	[1]  6  💬
20	Neupro 8 mg/24 h parche transdérmico	-	-	-	-	[1]  6  💬
21	Neupro 8 mg/24 h transdermal patch	-	-	-	-	[1]  6  💬
22	Neupro 8mg/24h transdermal patch	-	-	-	-	[1]  6  💬
23	Neupro*28cer 2mg/24h	-	-	-	-	[1]  6  💬
24	Neupro*28cer 4mg/24h	-	-	-	-	[1]  6  💬
25	Neupro*28cer 6mg/24h	-	-	-	-	[1]  6  💬
26	Neupro*28cer 8mg/24h	-	-	-	-	[1]  6  💬
27	Neupro*7cer 4mg/24h	-	-	-	-	[1]  6  💬
28	Neupro*7cer 6mg/24h	-	-	-	-	[1]  6  💬
29	Neupro*7cer 8mg/24h	-	-	-	-	[1]  6  💬
30	Neupro®	-	-	-	-	[1]  6  💬
31	Other: neupro 4 mg / 24 hr. transdermal patch	-	-	-	-	[1]  6  💬
32	Other: rotigotine	Rotigotine	[1] D05768 💬	[1] DRD2 💬	[8] Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway	[1]  6  💬
33	Rotigotine	Rotigotine	[1] D05768 💬	[1] DRD2 💬	[8] Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway	[1]  6  💬
34	Rotigotine (reference product pr 2.1.1)	Rotigotine	[1] D05768 💬	[1] DRD2 💬	[8] Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway	[1]  6  💬
35	Rotigotine (test product pr 2.3.1)	Rotigotine	[1] D05768 💬	[1] DRD2 💬	[8] Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway	[1]  6  💬
36	Rotigotine hydrochloride	Rotigotine	[1] D05768 💬	[1] DRD2 💬	[8] Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway	[1]  6  💬
37	Rotigotine nasal spray	Rotigotine	[1] D05768 💬	[1] DRD2 💬	[8] Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway	[1]  6  💬
38	Rotigotine transdermal patch	Rotigotine	[1] D05768 💬	[1] DRD2 💬	[8] Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway	[1]  6  💬
39	Rotigotine transdermal patch 2mg/24h(10cm2)	Rotigotine	[1] D05768 💬	[1] DRD2 💬	[8] Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway	[1]  6  💬
40	Rotigotine transdermal patch 4mg/24h (20cm2)	Rotigotine	[1] D05768 💬	[1] DRD2 💬	[8] Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway	[1]  6  💬
41	Rotigotine transdermal patch 6mg/24h (30cm2)	Rotigotine	[1] D05768 💬	[1] DRD2 💬	[8] Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway	[1]  6  💬
42	Rotigotine transdermal patch 8mg/24h (40cm2)	Rotigotine	[1] D05768 💬	[1] DRD2 💬	[8] Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway	[1]  6  💬
43	Rotigotine tts (test)	Rotigotine	[1] D05768 💬	[1] DRD2 💬	[8] Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway	[1]  6  💬
44	Rotigotine, extended-release microspheres	Rotigotine	[1] D05768 💬	[1] DRD2 💬	[8] Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway	[1]  6  💬

Back to top